Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
Journal Article
Lovic, D., Narayan P., Pittaras A., Faselis C., Doumas M., & Kokkinos P. (2017).  Left ventricular hypertrophy in athletes and hypertensive patients.. J Clin Hypertens (Greenwich). 19(4), 413-417.
Douma, S., Kamparoudis A., Petidis K., Anyfanti P., Doumas M., Gkaliagkousi E., et al. (2012).  Leiomyosarcoma of renal vein, initially resembling pheochromocytoma.. Clin Exp Hypertens. 34(6), 429-31.
Triantafyllou, A., Anyfanti P., & Doumas M. (2012).  Letter by Triantafyllou et al regarding article, "Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study".. Circulation. 126(1), e12; author reply e14.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2017).  Liraglutide and Renal Outcomes in Type 2 Diabetes.. N Engl J Med. 377(22), 2196.
Patoulias, D., Doumas M., Kotsis V., Stavropoulos K., Imprialos K., Zografou I., et al. (2019).  Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis.. Curr Diabetes Rev.
Reklou, A., Lazaridis A., Nikolaidou B., Kadiltzoglou P., & Doumas M. (2014).  Macro and microcirculation damage and incident hypertension: predictors of progression?. J Hypertens. 32(5), 1154.
Doumas, M., Anyfanti P., & Triantafyllou A. (2012).  Management of erectile dysfunction: do not forget hypertension.. Arch Intern Med. 172(7), 597-8; discussion 598.
Doumas, M., Lazaridis A., & Reklou A. (2013).  Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations.. Hypertension. 62(4), e21.
Schoina, M., Loutradis C., Memmos E., Dimitroulas T., Pagkopoulou E., Doumas M., et al. (2020).  Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis.. Hypertens Res.
Mitroulis, I., Kambas K., Anyfanti P., Doumas M., & Ritis K. (2011).  The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.. Expert Opin Ther Targets. 15(1), 75-89.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Doumas, M., Tsioufis C., Faselis C., Lazaridis A., Grassos H., & Papademetriou V. (2014).  Non-interventional management of resistant hypertension.. World J Cardiol. 6(10), 1080-90.
Faselis, C., Boutari C., Doumas M., Imprialos K., Stavropoulos K., & Kokkinos P. (2017).  Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun.. Curr Pharm Des. 23(10), 1540-1550.
Doumas, M., Stavropoulos K., & Imprialos K. (2017).  Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?. J Hypertens. 35(5), 950-952.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2017).  Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.. N Engl J Med. 377(25), 2502.
Doumas, M., Imprialos K. P., Stavropoulos K., & Athyros V. G. (2018).  Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?. J Clin Hypertens (Greenwich). 20(3), 469-471.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Petidis, K., Grammatiki M., & Doumas M. (2013).  Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity.. J Hypertens. 31(10), 2103.
Gkaliagkousi, E., Gavriilaki E., Yiannaki E., Markala D., Papadopoulos N., Triantafyllou A., et al. (2014).  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.. Am J Hypertens. 27(4), 571-8.
Imprialos, K. P., Stavropoulos K., Doumas M., Skalkou A., Zografou I., & Athyros V. G. (2018).  The potential role of statins in treating liver disease.. Expert Rev Gastroenterol Hepatol. 12(4), 331-339.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2014).  Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit.. Expert Rev Cardiovasc Ther. 12(3), 295-6.
Schoina, M., Loutradis C., Theodorakopoulou M., Dimitroulas T., Triantafillidou E., Doumas M., et al. (2020).  The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.. Microcirculation. e12665.
Triantafyllou, A., Douma S., Petidis K., Doumas M., Panagopoulou E., Pyrpasopoulou A., et al. (2010).  Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece.. Rural Remote Health. 10(2), 1225.
Douma, S., Petidis K., Doumas M., Papaefthimiou P., Triantafyllou A., Kartali N., et al. (2008).  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.. Lancet. 371(9628), 1921-6.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.